About

Dr. Angelica Grasso is a pioneering urologic surgeon and researcher whose work centers on advancing robotic surgery for prostate and bladder cancer. Her major contributions include developing a novel statistical tool to predict extracapsular extension of prostate cancer, enabling safer, graded nerve-sparing during radical prostatectomy—a study cited 58 times. She has also been at the forefront of evaluating next-generation robotic platforms, publishing the first head-to-head comparison of the Hugo RAS and Versius CMR systems in a preclinical setting (13 citations) and the first case of robot-assisted radical cystectomy with intracorporeal neobladder using Hugo RAS (35 citations). Her research on salvage robot-assisted laparoscopic prostatectomy for radiorecurrent cancer (40 citations) and the role of extended pelvic lymphadenectomy (17 citations) has shaped clinical decision-making. Dr. Grasso has also critically examined the educational value of live surgery, sparking important debate. With over 200 total citations across her most-cited works, she is recognized as a key voice in the evolution of minimally invasive urologic oncology, particularly in the adoption and assessment of emerging robotic systems.

Research Focus

Key Achievements

9
H-Index
12
Papers
252
Total Citations
21
Avg Citations/Paper
🏆 Most Cited Paper
A novel tool for predicting extracapsular extension during graded partial nerve sparing in radical prostatectomy
58 citations · 2017
📈 Most Prolific Year: 2017 (3 Papers)
🤝 Key Collaborators: 84
🏛 Institutions: University of Milan, Memorial Sloan Kettering Cancer Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago